Safety and Use of MLC601/MLC901 (NeuroAiD^TM) in Primary Intracerebral Hemorrhage: A Cohort Study from the NeuroAiD Safe Treatment Registry

Benzer Materyaller

• NeuroAid™-II (MLC901) provides neuroprotection and enhances neuronal cell survival against kainic acid-induced excitotoxicity in vitro by activating the PI3K/AKT pathway
  Yazar:: Anam Anjum, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-03-01)
• The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild‐to‐moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double‐blind, placebo‐controlled trial
  Yazar:: Christopher L.H. Chen, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-01-01)
• Safety and Use of MLC601/MLC901 (NeuroAiD^TM) in Primary Intracerebral Hemorrhage: A Cohort Study from the NeuroAiD Safe Treatment Registry
  Yazar:: Ramesh Kumar, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-07-01)
• Translational Medicine in Acute Ischemic Stroke and Traumatic Brain Injury—NeuroAiD Trials, from Traditional Beliefs to Evidence-Based Therapy
  Yazar:: Narayanaswamy Venketasubramanian, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-06-01)
• OBSERVING THE OUTCOME OF USING NEUROAID [MLC 601] ON A SAMPLE OF IRAQI STROKE PATIENTS
  Yazar:: Zaki N Hasan, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-04-01)